GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aelis Farma SA (XPAR:AELIS) » Definitions » EV-to-FCF

Aelis Farma (XPAR:AELIS) EV-to-FCF : -0.71 (As of Apr. 17, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Aelis Farma EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Aelis Farma's Enterprise Value is €8.57 Mil. Aelis Farma's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €-12.00 Mil. Therefore, Aelis Farma's EV-to-FCF for today is -0.71.

The historical rank and industry rank for Aelis Farma's EV-to-FCF or its related term are showing as below:

XPAR:AELIS' s EV-to-FCF Range Over the Past 10 Years
Min: -12.2   Med: -9.71   Max: 6.12
Current: -0.77

During the past 8 years, the highest EV-to-FCF of Aelis Farma was 6.12. The lowest was -12.20. And the median was -9.71.

XPAR:AELIS's EV-to-FCF is ranked worse than
100% of 451 companies
in the Biotechnology industry
Industry Median: 2.1 vs XPAR:AELIS: -0.77

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-17), Aelis Farma's stock price is €1.18. Aelis Farma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.556. Therefore, Aelis Farma's PE Ratio (TTM) for today is At Loss.


Aelis Farma EV-to-FCF Historical Data

The historical data trend for Aelis Farma's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aelis Farma EV-to-FCF Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial - - -10.52 -11.99 -2.30

Aelis Farma Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.52 - -11.99 - -

Competitive Comparison of Aelis Farma's EV-to-FCF

For the Biotechnology subindustry, Aelis Farma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aelis Farma's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aelis Farma's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Aelis Farma's EV-to-FCF falls into.


;
;

Aelis Farma EV-to-FCF Calculation

Aelis Farma's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=8.569/-11.996
=-0.71

Aelis Farma's current Enterprise Value is €8.57 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aelis Farma's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €-12.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aelis Farma  (XPAR:AELIS) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Aelis Farma's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.18/-0.556
=At Loss

Aelis Farma's share price for today is €1.18.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aelis Farma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.556.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Aelis Farma EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Aelis Farma's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Aelis Farma Business Description

Traded in Other Exchanges
Address
146, rue Leo Saignat, Bordeaux, FRA, 33077
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases.

Aelis Farma Headlines

No Headlines